JYNT The Joint Corp.
Healthcare$9.22+3.02%ClosedMarket Cap: $131.4M
As of 2026-05-26
Valuation
P/E (TTM)
43.01
PEG
0.32
P/B
8.20
P/S
2.25
EV/EBITDA
42.73
DCF Value
$2.62
FCF Yield
2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.9%
Operating Margin
1.2%
Net Margin
5.7%
ROE
16.9%
ROA
5.6%
ROIC
2.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $14.8M | 79.0% | $899.0K | $1.3M | $— | — |
| Q4 null | $15.2M | 81.4% | $743.9K | $991.1K | $— | — |
| FY null | $54.9M | 79.6% | $-905.5K | $2.9M | $— | — |
| Q3 null | $13.4M | 80.1% | $160.9K | $855.0K | $— | — |
| Q2 null | $13.3M | 79.1% | $-1.1M | $93.4K | $— | — |
| Q1 null | $13.1M | 77.3% | $-678.5K | $967.8K | $— | — |
| Q4 null | $-38.3M | 108.2% | $3.8M | $-2.7M | $— | — |
| FY null | $52.2M | 77.9% | $-1.9M | $-5.8M | $— | — |
| Q3 null | $30.2M | 90.7% | $-3.2M | $-3.2M | $— | — |
| Q2 null | $12.6M | 77.7% | $-1.8M | $-3.6M | $— | — |
| Q1 null | $12.2M | 77.8% | $-426.6K | $947.0K | $— | — |
| Q4 2023 | $30.6M | 90.6% | $-147.4K | $-11.0M | $-0.75 | — |